Advertisement

Urolithiasis pp 603-609 | Cite as

1,25(OH)2D3 in Humans: Regulation in Health and Role in Urolithiasis

  • J. LemannJr.
  • R. W. Gray

Abstract

Hypercalciuria is one of the risk factors for calcium oxalate (CaOx)/ apatite urolithiasis (1–3). The extra Ca excreted in the urine of stone formers (idiopathic hypercalciuria, IH) is almost entirely derived from the diet as a consequence of increased efficiency of intestinal Ca absorption (2–5).

Keywords

Primary Hyperparathyroidism Calcium Oxalate Intestinal Calcium Absorption Hypophosphatemic Rickets Idiopathic Hypercalciuria 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    RH Flocks, Calcium and phosphorous excretion in the urine of patients with renal or ureteral calculi, J. Am. Med. Soc. 113: 1146 (1939).Google Scholar
  2. 2.
    PH Henneman, PH Benedict, AP Forbes, and HR Dudley, Idiopathic hypercalciuria, NEJM 259: 802 (1958).PubMedCrossRefGoogle Scholar
  3. 3.
    CYC Pak, M Ohata, EC Lawrence, and W Snyder, The hypercalciurias: causes, parathyroid functions and diagnostic criteria, J. Clin. Invest. 54: 387 (1974).PubMedCrossRefGoogle Scholar
  4. 4.
    J Lemann, Jr., Idiopathic hypercaliuria, in: “Nephrolithiasis,” FL Coe, ed., Churchill Livingston, New York (1980), and in: “Contemporary Issues in Nephrology,” MB Brenner and JH Stein, eds., Churchill Livingston, New York (vol. 5, 1980).Google Scholar
  5. 5.
    FL Coe and MJ Favus, Disorders of stone formation, in: “The Kidney,” 3rd Edition, BM Brenner and Fc Rector, Jr., WB Saunders Co., Philadelphia (1986).Google Scholar
  6. 6.
    HF DeLuca, The vitamin D story: a collaborative effort of basic science and clinical medicine, FASEB J. 2: 224 (1988).PubMedGoogle Scholar
  7. 7.
    JC Gallagher, BL Riggs, J Eisman, and A Hamstra, Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients, J. Clin. Invest. 64: 729 (1979).PubMedCrossRefGoogle Scholar
  8. 8.
    RA Kapler, MR Haussler, LJ Deftos, H Bone, and CYC Pak, The role of lα-25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathryoidism and absorptive hypercalciuria, J. Clin. Invest. 59: 756 (1977).CrossRefGoogle Scholar
  9. 9.
    DR Wilz, RW Gray, JH Domínguez, and J Lemann, Jr., Plasma 1,25(OH)2-vitamin D concentrations and net intestinal calcium, phosphate and magnesium absorption in humans, Am. J. Clin. Nutr. 32: 2052 (1979).PubMedGoogle Scholar
  10. 10.
    MS Sheikh, A ramirez, M Emmett, et al., Role of vitamin D-dependent and vitamin D-independent mechanisms in absorption of food calcium, J. Clin. Invest. 81: 126 (1988).PubMedCrossRefGoogle Scholar
  11. 11.
    WJ Maierhofer, J Lemann, Jr., RW Gray, et al., Dietary calcium and serum 1,25(OH)2D3 concentrations as determinants of calcium balance in healthy men, Kidney Int. 26: 752 (1984).PubMedCrossRefGoogle Scholar
  12. 12.
    ND Adams, RW Gray, and J Lemann, Jr., The effects of oral CaCO3 loading and dietary calcium deprivation on plasma 1,25-dihydroxyvitamin D concentrations in healthy adults, J. Clin. Endocrinol. Metab. 48: 1008 (1979).PubMedCrossRefGoogle Scholar
  13. 13.
    Jp Bilezekian, RE Canfield, TP Jacobs, et al., Response of lα-dihydroxyvitamin D to hypocalcemia in human subjects, NEJM 299: 437 (1978).CrossRefGoogle Scholar
  14. 14.
    JA Eisman, JD Wark, RL Prince, et al., Modulation of plasma 1,25-dihydroxyvitamin D in man by stimulation and suppression tests, Lancet 2: 931 (1979).PubMedCrossRefGoogle Scholar
  15. 15.
    AE Broadus, RL Horst, R Lang, et al., The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal stone formation in primary hyperparathyroidism, NEJM 302: 421 (1980).PubMedCrossRefGoogle Scholar
  16. 16.
    AB Korker, RW Gray, HL Henry, JG Kleinman, SB Blumenthall, and JC Garancis, Evidence that Stimulation of 1,25(OH)2D3 production in primary cultures of mouse kidney cells by cyclic AMP requires new protein synthesis, J. Bone Mineral Res. 2: 517 (1987).CrossRefGoogle Scholar
  17. 17.
    AA Prtale, BP Halloran, MM Murphy, and RC Morris, Jr., Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans, J. Clin. Invest. 77: 7 (1986).CrossRefGoogle Scholar
  18. 18.
    KL Insogna, AE Broadus, and JM Gertner, Impaired phosphorus conservation and 1,25-dihydroxyvitamin D generation during phosphorus deprivation in familial hypophosphatemic rickets, J. Clin. Invest. 71: 1562 (1983).PubMedCrossRefGoogle Scholar
  19. 19.
    EG Lufkin, R Kumar, and H Heath, III, Hyperphosphatemic tumoral calcinosis: effects of phosphate depletion on vitamin D metabolism, and of acute hypocalcemia on parathyroid hormone secretion and action, J. Clin. Endocrinol. Metab. 56: 1319 (1983).PubMedCrossRefGoogle Scholar
  20. 20.
    WJ Maierhofer, RW Gray, and J Lemann, Jr., Phosphate deprivation increases serum l,25(OH)2-vitamin D concentrations in healthy men, Kidney Int. 25: 57 (1984).CrossRefGoogle Scholar
  21. 21.
    RW Gray, The control of plasma l,25(OH)2-vitamin D concentrations by calcium and phosphorus in the rat: effects of hypophysectomy, Calcif. Tissue Int. 33: 485 (1981).PubMedCrossRefGoogle Scholar
  22. 22.
    RW Gray and TL Garthwaite, Activation of renal 1,25-dihydroxyvitamin D3 synthesis by phosphate deprivation: evidence for a role of growth hormone, Endocrinology 116: 189 (1985).PubMedCrossRefGoogle Scholar
  23. 23.
    RW Gray, Evidence that somatomedins mediate the effect of hypophosphatemia to increase serum 1,25-dihydroxyvitamin D3 levels in rats, Endocrinology 121: 504 (1987).PubMedCrossRefGoogle Scholar
  24. 24.
    EM Spencer and BP Halloran, The stimulation of 25-hydroxyvitamin D-1-hydroxylase by dietary phosphorus restriction requires insulin-like growth factor-1(IGF-1), Abstr. 7th Workshop on Vitamin D (1988).Google Scholar
  25. 25.
    JM Gertner and MD Harbison, Growth hormone (GH) is necessary for increased calcitriol generation but not phosphate conservation during phosphorus deprivation in man, Abstr. 7th Workshop on Vitamin D (1988).Google Scholar
  26. 26.
    Y Nesbitt, B Lobaugh, and MK Drezner, Calcitonin stimulation of renal 25-hydroxyvitamin D-lα-hydroxylase activity in hypophosphatemic mice, J. Clin. Invest. 79: 15 (1987).PubMedCrossRefGoogle Scholar
  27. 27.
    Tieder, D Modai, U Shaked, et al., “Idiopathic hypercalciuria” and hereditary hypophosphatemic rickets, NEJM 316: 125 (1987).PubMedCrossRefGoogle Scholar
  28. 28.
    KW Lyles, DL Halsey, NE Friedman, et al., Correlations of serum concentrations of 1,25-dihydroxyvitamin D, phosphorus, and parathyroid hormone in tumoral calcinosis, J. Clin. Endocrinol. Metab. 67: 88 (1988).PubMedCrossRefGoogle Scholar
  29. 29.
    H Kawashima, S Torikai, and K Kurokawa, Calcitonin selectively stimulates 25-hydroxyvitamin D3-lα-hydroxylase in the proximal straight tubule of the rat kidney, Nature 291: 327 (1981).PubMedCrossRefGoogle Scholar
  30. 30.
    FH Shen, DJ Baylink, RL Nielsen, et al., Increased serum 1,25-dihydroxyvitamin D in idiopathic hypercalciuria, J. Lab. Clin. Med. 90: 955 (1977).PubMedGoogle Scholar
  31. 31.
    RW Gray, DR Wilz, J Lemann, Jr., et al., The importance of phosphate in regulating plasma l,25(OH)2-vitamin D levels in humans: studies in healthy subjects, in calcium stone formers and in patients with primary hyperparathyroidism, J. Clin. Endocrinol. Metab. 45: 299 (1977).PubMedCrossRefGoogle Scholar
  32. 32.
    JE Zerwekj and CYC Pak, Selective effects of thiazide therapy on serum 1α, 25-hydroxyvitamin D and intestinal calcium absorption in renal and absorptive hypercalciurias, Metabolism 29: 13 (1980).CrossRefGoogle Scholar
  33. 33.
    FL Coe, MJ Favus, T Crockett, et al., Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects, Am. J. Med. 72: 25 (1982).PubMedCrossRefGoogle Scholar
  34. 34.
    AE Broadus, KL Insogna, R Lang, et al., A consideration of the hormonal basis and phosphate-leak hypothesis of absorptive hypercalciuria, J. Clin. Endocrinol. Metab. 58: 161 (1984).PubMedCrossRefGoogle Scholar
  35. 35.
    P Bataille, R Bouillon, A Fournier, et al., Increased plasma concentrations of total and free 1,25(OH)2D3 in calcium stone formers with idiopathic hypercalciuria, Contr. Nephrol. 58: 137 (1987).Google Scholar
  36. 36.
    A Halabe, T Weins, L Hagen, et al., Parathyroid gland suppressbility in idiopathic hypercalciuria, J. Bone Mineral Res. 3: Suppl. I, S167 (1988).Google Scholar
  37. 37.
    KL Insogna, AE Broadus, BE Dreyer, AF Ellison, and JM Gertner, Elevated production rate of 1,25-dihydroxyvitamin D in patients with absorptive hypercalciuria, J. Clin. Endocrinol. Metab. 61: 490 (1985).PubMedCrossRefGoogle Scholar
  38. 38.
    AE Broadus, M Dominguez, and FC Barter, Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups, J. Clin. Endocrin. Metab. 47: 751 (1978).CrossRefGoogle Scholar
  39. 39.
    JE Carothers, NM Kurtz, and J Lemann, Jr., Error introduced by specimen handling before determination of inorganic phosphate concentrations in plasma and serum, Clin. Chem. 22: 1909 (1976).PubMedGoogle Scholar
  40. 40.
    AB Korker, Reduced binding of 3H-1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure, NEJM 316: 1573 (1987).CrossRefGoogle Scholar
  41. 41.
    MJ Favus, V Tembe, FJ Coe, K Ambrosic, M Tanklefsky, Evidence for in vivo up-regulation of the intestinal 1,25(OH)2D3 receptor during dietary calcium restriction in the rat, J. Bone Min. Res. 2: Suppl.1, 507 (1987).Google Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • J. LemannJr.
    • 1
    • 2
  • R. W. Gray
    • 1
    • 2
  1. 1.Departments of Medicine and Biochemistry and Clinical Research CenterMedical College of WisconsinMilwaukeeUSA
  2. 2.Froedtert Memorial Lutheran HospitalMilwaukeeUSA

Personalised recommendations